Legal Representation
Attorney
John M. Guynn
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-19)
Due Date
March 19, 2025
Grace Period Ends
September 19, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 19, 2025 | PUM1 | O | OFFICE ACTION ISSUED POU1 | Loading... |
| Mar 17, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 26, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Mar 19, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Mar 19, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 13, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 12, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jan 30, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 30, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 29, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 24, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 19, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 19, 2018 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 19, 2018 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Sep 28, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 28, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 5, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 5, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 29, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 3, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 3, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 14, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 28, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 27, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 27, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 27, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 27, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 6, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 29, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 29, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 29, 2018 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 27, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 25, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 25, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 21, 2017 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 21, 2017 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 21, 2017 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 31, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 31, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 31, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 10, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 10, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 10, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 5, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 14, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, for treating inflammatory conditions, for providing immunity from disease, antioxidants in the nature of food supplements, and pharmaceutical preparations for improving memory and for treating deficits in learning and memory; dietetic food adapted for medical use and dietetic substances adapted for medical use in the nature of polygonum minus, namely, herbs for medicinal purposes; flavonoids, namely, quercetin-3-glucuronide and Quercitrin, for use as a dietary supplement, namely, to cover usage in food, beverage and skin care, and anti-aging products; medicinal infusions for treating inflammatory conditions, for providing immunity from disease, antioxidants in the nature of food supplements, and pharmaceutical preparations for improving memory and for treating deficits in learning and memory; dietary supplements for humans; pharmaceutical preparations for skin care; plant herbal extract for medicinal purposes; all of the foregoing containing kesum as an ingredient
First Use Anywhere:
Jan 18, 2018
First Use in Commerce:
Jan 18, 2018
Classification
International Classes
005